frankw17

Author Archives

Tax-Free Oil Wealth

This is a request about an opinion re. ”Tax-Free Oil Wealth: The Perfect Retirement Plan” currently being pitched by Brian Hicks at Wealth Daily. He makes this thing sound like a phenomenal investment, tax free, that will make you incredibly wealthy. This reminds me of that old adage ”if it sounds to good to be […]

Tax-Free Oil Wealth

Travis, is a request about an opinion re. ”Tax-Free Oil Wealth: The Perfect Retirement Plan” currently being pitched by Brian Hicks at Wealth Daily. He makes this thing sound like a phenomenal investment, tax free, that will make you incredibly wealthy. This reminds me of that old adage ”if it sounds to good to be […]

Recent Author Comments

On Microblog: Discussion page for Arch Therapeutics (ARTH)
Long $MEIP;MEI Pharma (NASDAQ:MEIP) was upgraded by analysts at Wells Fargo & Co from a "market perform" rating to an "outperform" rating. current price of $4.90. NP $MRNS;Marinus Pharmaceuticals (NASDAQ:MRNS) is now covered by analysts at LADENBURG THALM[...]
On Solved: Robinson's "Shape-Shifting 'Smart Metal'" Tease for 4,000% Gains?
Good article Travis, but Robinson is gilding the lily. There has been talk of gallium arsenide overtaking silicon for well over 40 years that I'm aware of, but it has never happened and anyone who thinks this investment will achieve a 45,798% sales surge[...]
On Friday File: Premier, Estre, Naspers, NVIDIA and gold coins
Travis, congratulations on your TTD investment. I wish I had followed you into it some time back. Regards, Frank[...]
On Microblog: Gold, Silver, Copper, and Hard Assets…Fall 2017
Long $IVPAF and $CTQEF; Great post HN. Thanks. Regards, Frank[...]
On Biotech Discussion... continued
$AKAO, NP; Good prognostication STM, as $AKAO traded from a low of $10.10 up to a high of $12.40 today. Furthermore it's up $.44 and the last trade was $11.50 at 6:21PM EST. Regards, Frank[...]
On Biotech Discussion... continued
$AKAO, NP: Ben, this report seems very positive, but the stock is now trading down $4.75 at $9.90 after hours. If this is selling on the news, it appears someone is taking things to the extreme. Regards, Frank[...]
On Looking Out for Your Own Wellbeing
Great article "Doc" as usual! One might consider Kaiser for free yearly physicals under Medicare. Furthermore, you get to choose your PCP. Regards, Frank[...]
On Biotech Discussion... continued
Good post Penny. It would be different if the TD posters offered something constructive to support their position, but many seem to just have a negative bent! Regards, Frank[...]
On Biotech Discussion... continued
Long $MGEN; Brokerage firm Jefferies has been weighing in on a number of healthcare stocks this week. This morning, the firm turned its attention to Miragen Therapeutics Inc (NASDAQ:MGEN), initiating coverage with a "buy" rating and $14 price target -- w[...]
On Biotech Discussion... continued
Long $EBIO; Eleven Biotherapeutics (NASDAQ:EBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $2.00 price target on the stock. 77.0% upside from the current price of $1.13. Regards, Frank[...]
On Biotech Discussion... continued
No longer long $PTI. Feddie, I'm not sure I would agree with that statement. I saw the following comments from "Schaeffer's Research" after hours: KERRISDALE CAPITAL GOES SHORT ON PTI STOCK Proteostasis Therapeutics has dropped 22.5% to trade at $5.42,[...]
On Biotech Discussion... continued
Long $PIRS; Pieris Pharmaceuticals (NASDAQ:PIRS) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $13.00 price target on the stock. 79.6% upside from the current price of $7.24. 6 brokerages have issued 1 year price obj[...]
On Biotech Discussion... continued
The folks at ValuEngine must be the most astute analysts in the business based upon this "upgrade"? Aptose Biosciences (NASDAQ:APTO) (TSE:APS) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a researc[...]
On Biotech Discussion... continued
Long $PTI, thanks to Dr. KSS. Ben, the volume on $PTI is amazing this AM, 1.5 hours into today's trading and the stock has already traded almost 19M shares. Contrast that fact with the float of the stock at 14.5M, per Yahoo Finance. Regards, Frank[...]
On Biotech Discussion... continued
tanglewood, after reading this article, one would have to question why anyone would read any article on "screwed again" unless you were 100% convinced that the author was indeed reputable! Great article, thank you. Regards, Frank[...]
On Biotech Discussion... continued
Long $SRNE and $APTO: I missed these updates earlier in the week. My apologies if this was previously posted. Aptose Biosciences (NASDAQ:APTO) (TSE:APS) was given a new $6.00 price target on by analysts at HC Wainwright on Wednesday. They now have a "bu[...]
On Biotech Discussion... continued
NT, Greats summary of various events. Thank you Ben. You are indeed the glue that holds this thread together, especially for the last few months. You are the "jewel of the south"! Regards, Frank[...]
On Biotech Discussion... continued
Ben, NP, you would have to have cast iron cohones to trade PTGX due to the fact that the bid is currently $20.45 and the ask is $21.57, now that's a spread! Regards, Frank[...]
On Microblog: TICKED OFF !
hipockets, is this thread still open? The last post is dated 11/2015. Regards, Frank[...]
On Biotech Discussion... continued
Beemo, I just sold $CORT a few days ago. I had held it for almost 2 years and it was a very profitable transaction for me. I think this was a stock Travis previously owned (If not I'll still give him credit). However, when it dropped almost 50% this mon[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.